CARTICEL (Vericel Corporation)
Welcome to the PulseAid listing for the CARTICEL drug offered from Vericel Corporation. This Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Vericel Corporation |
NON-PROPRIETARY NAME: | autologous cultured chondrocytes |
SUBSTANCE NAME: | AUTOLOGOUS CULTURED CHONDROCYTES |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] |
ROUTE: | INTRA-ARTICULAR |
DOSAGE FORM: | IMPLANT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1905-06-19 |
END MARKETING DATE: | 0000-00-00 |
CARTICEL HUMAN PRESCRIPTION DRUG Details:
Item Description | CARTICEL from Vericel Corporation |
LABELER NAME: | Vericel Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12000000(1-Jan) |
START MARKETING DATE: | 1905-06-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69866-1025_45501f23-533e-4c7a-9203-2974d40c8a26 |
PRODUCT NDC: | 69866-1025 |
APPLICATION NUMBER: | BLA103661 |
Other AUTOLOGOUS CULTURED CHONDROCYTES Pharmaceutical Manufacturers / Labelers: